CELEX: 62019TN0792
Language: en
Date: 2019-11-11 00:00:00
Title: Case T-792/19: Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)

13.1.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 10/50
            
         
      Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
      (Case T-792/19)
      (2020/C 10/61)
      Language in which the application was lodged: German
      
         Parties
      
      
         Applicant: Agepha Pharma s. r. o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Apogepha Arzneimittel GmbH (Dresden, Germany)
      
         Details of the proceedings before EUIPO
      
      
         Applicant for the trade mark at issue: Applicant
      
         Trade mark at issue: Application for EU word mark AGEPHA — EU trade mark application No 7 007 909
      
         Procedure before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Second Board of Appeal of EUIPO of 26 August 2019 in Case R 386/2019-2
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  vary the contested decision and reject the opposition;
               
            
                  —
               
               
                  in the alternative, annul the contested decision;
               
            
                  —
               
               
                  order EUIPO and the other party to pay the costs incurred in the proceedings before the Second Board of Appeal and in the present proceedings.
               
            
         Pleas in law
      
      
                  —
               
               
                  infringement of Article 42(2) of Council Regulation (EC) No 207/2009;
               
            
                  —
               
               
                  infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.